After months of discussion, President Donald Trump’s new direct-to-consumer pharmaceutical site, TrumpRx, officially launched ...

Late last year, Lilly was the first pharmaceutical stock to reach a $1 trillion valuation.

The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than ...

The Trump Administration launches the TrumpRx website on Thursday, and we're breaking down what the health care initiative is and the savings patients will see on the weight loss drug Zepbound ...

Eli Lilly's full-year guidance comes in stark contrast to the outlook of Novo Nordisk, which warned it sees sales and profit ...

Mounjaro and Zepbound generated a combined $11.7 billion in sales for the company in its most recent quarter.

Menopause can accelerate age-related weight gain, increasing a woman’s odds of becoming overweight or obese, researchers said in background notes. The change of life also can cause symptoms like hot ...

Eli Lilly and Co. shares soared in midday trading Wednesday after the drugmaker reported fourth-quarter results that topped ...

Joe Budden discusses using Zepbound, fitness changes, and health awareness during an appearance on 'Club Shay Shay.' ...

If compounded and generic GLP-1 drugs work as well as brand-name versions, they could fill a significant void by offering personalized dosing and greater affordability.

A trial was conducted comparing weight loss medications Zepbound and Wegovy. Results from the trial found that participants who took Zepbound lost more weight than those who took Wegovy. Side effects ...